IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masinick, S. A.
Right arrow Articles by Hazlett, L. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masinick, S. A.
Right arrow Articles by Hazlett, L. D.

Investigative Ophthalmology & Visual Science, Vol 38, 910-918, Copyright © 1997 by Association for Research in Vision and Ophthalmology


ARTICLES AND REPORTS

Secretory IgA inhibits Pseudomonas aeruginosa binding to cornea and protects against keratitis

SA Masinick, CP Montgomery, PC Montgomery and LD Hazlett
Department of Anatomy and Cell Biology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

PURPOSE: To determine whether secretory IgA (SIgA) antibody inhibits Pseudomonas aeruginosa binding to cornea in vitro and if boosting SIgA antibody in tears using heat-killed P. aeruginosa as an immunizing antigen is protective in vivo in experimentally induced bacterial keratitis in the mouse. METHODS: SIgA, immunoglobulin-G, immunoglobulin- M, and an undiluted crude human milk preparation were tested in vitro for their ability to inhibit P. aeruginosa binding to the scarified corneas of adult (6 weeks to 6 months of age) mice by topical application of each before similar delivery of the bacterial inoculum. Scanning electron microscopy (scanning EM) was used to quantitate bacterial adherence. In vivo mice were immunized topically with heat- killed P. aeruginosa or sham immunized by application of a similar volume of phosphate-buffered saline (PBS). Tears were collected from both groups of mice and levels of immunoglobulins (Igs) measured by enzyme-linked immunosorbent assay (ELISA). After the second immunization, the same two groups were challenged ocularly with 5.0 x 10(7) colony forming units P. aeruginosa and the response to infection graded. RESULTS: In vitro, after a 30-minute preincubation with Igs, SIgA (250 micrograms/ml) significantly decreased P. aeruginosa binding to cornea in vitro when compared to the number of bacteria bound in PBS control specimens, and binding reduction was concentration dependent. In vivo, 15 days after a second ocular topical immunization, tear SIgA was elevated significantly and was specific for P. aeruginosa when measured by ELISA. In vivo, corneal disease response grades in the heat- killed antigen immunized mice also were significantly less severe when compared to sham-immunized mice. CONCLUSIONS: SIgA significantly inhibits binding of P. aeruginosa to the wounded mouse cornea in vitro, and inhibition is concentration dependent. In vivo, specific antipseudomonal SIgA in mouse tears can be elicited by topical ocular immunization with heat-killed P. aeruginosa, and a significant number of immunized animals with elevated levels of SIgA in their tears exhibited less severe ocular disease after bacterial challenge.


This article has been cited by other articles:


Home page
IOVSHome page
J. A. Lomholt and M. Kilian
Degradation of Uniquely Glycosylated Secretory Immunoglobulin A in Tears from Patients with Pseudomonas aeruginosa Keratitis
Invest. Ophthalmol. Vis. Sci., November 1, 2008; 49(11): 4939 - 4944.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
E. Knop, N. Knop, and P. Claus
Local Production of Secretory IgA in the Eye-Associated Lymphoid Tissue (EALT) of the Normal Human Ocular Surface
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2322 - 2329.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. S. F. Kwong, D. J. Evans, M. Ni, B. A. Cowell, and S. M. J. Fleiszig
Human Tear Fluid Protects against Pseudomonas aeruginosa Keratitis in a Murine Experimental Model
Infect. Immun., May 1, 2007; 75(5): 2325 - 2332.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. Ni, D. J. Evans, S. Hawgood, E. M. Anders, R. A. Sack, and S. M. J. Fleiszig
Surfactant Protein D Is Present in Human Tear Fluid and the Cornea and Inhibits Epithelial Cell Invasion by Pseudomonas aeruginosa
Infect. Immun., April 1, 2005; 73(4): 2147 - 2156.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. M. J. Fleiszig, M. S. F. Kwong, and D. J. Evans
Modification of Pseudomonas aeruginosa Interactions with Corneal Epithelial Cells by Human Tear Fluid
Infect. Immun., July 1, 2003; 71(7): 3866 - 3874.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
A. Thakur, J. Kyd, M. Xue, M. D. P. Willcox, and A. Cripps
Effector Mechanisms of Protection against Pseudomonas aeruginosa Keratitis in Immunized Rats
Infect. Immun., May 1, 2001; 69(5): 3295 - 3304.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the Association for Research in Vision and Ophthalmology